Cluster Headache Treatment Survey

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06011811

Enrollment

2487

Registered

2023-08-25

Start date

2023-06-29

Completion date

2025-06-28

Last updated

2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cluster Headache

Brief summary

The objective of this study is to survey patients with cluster headache about treatment effectiveness and their views on treatments. Participants will complete one brief questionnaire online.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with episodic or chronic cluster headache that has been diagnosed by a health care professional (no documentation is needed, participant must simply state that he or she has been diagnosed)

Exclusion criteria

* Unable to speak English (the survey is only in English) * Unable to use a computer to take the online survey * Unable to provide consent

Design outcomes

Primary

Measure	Time frame
Effectiveness of cluster headache treatment as assessed by a survey	at the time of survey completion, expected to be 6-12 months

Secondary

Measure	Time frame
Opinions on new cluster headache treatment as assessed by a survey	at the time of survey completion, expected to be 6-12 months

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMark J Burish, MD, PhD

The University of Texas Health Science Center, Houston

Outcome results